Venezuela Medicines Law Articles 18 and 67 Applied to Devices

1. Key takeaways

The Venezuelan Medicines Law (Ley de Medicamentos, Gaceta Oficial N° 37.006, August 3, 2000) is written for medicines, yet two of its mechanisms carry over to medical devices: the registration obligation established by Article 18, together with the rule that approval is published in the Official Gazette, and the prohibition on importing non-compliant products established by Article 67.

The conclusion that matters for manufacturers is that the public effect of a registration certificate derives from the act of publication in the Official Gazette, not from the physical issuance of the certificate itself. The authenticity and the validity of a certificate can therefore be verified independently through the Gazette, without relying on a photocopy supplied by the party that holds it.

This distinction is not academic. A registration that has been approved but not yet published is, in practice, not yet usable for third-party verification, and a certificate presented by a distributor without a matching Gazette entry has no confirmable standing. Building the verification routine around the Gazette rather than around the paper certificate is the single cheapest control a foreign manufacturer can install in the Venezuelan channel.

2. Legal basis

3. Expert insights

Insight 1: Article 18 splits registration and publication into two separate acts, and the split has practical value. Once a certificate has been issued, its effect against third parties comes from publication. When a company verifies the standing of a local partner it should search the Official Gazette for the corresponding entry rather than inspect a scanned certificate, because the cost of forging the latter is far lower than the cost of forging the former.

Insight 2: the prohibition in Article 67 was reactivated by the circular of July 9, 2026. Circular N° DGSACS-008/2026 requires that goods imported under legal regime 3 and legal regime 12 comply strictly with the health regulations in force and that a valid sanitary registration, an import permit and a list be submitted. This runs in the same direction as Article 67 and produces a double constraint, one at the level of legal liability and one at the level of customs clearance: a shipment can be refused at the border for a documentary gap even where the underlying registration is valid, and the registration holder can be exposed to liability for a shipment that entered without the required permit.

Insight 3: the boundary of the extension from medicines to devices is not clearly drawn. Venezuela has no dedicated medical device law, and device oversight has long borrowed the framework written for medicines and health products. As a result, some requirements, such as the practice of having a professional sponsor a registration, are of uncertain application in the device field, and in practice the position taken by the intake window at the time of filing governs. A company that plans on the basis of the medicines text alone will either over-prepare or, more dangerously, omit an item that the window expects.

The two articles also operate at different moments in the commercial cycle, and separating them clarifies who is responsible for what. Article 18 sits at the market-entry stage and produces an asset that belongs to the registration holder. Article 67 sits at the border and produces an obligation that falls on the importer of each consignment. In a typical Venezuelan arrangement the holder and the importer may be the same company or two different companies, and the manufacturer is neither. That is precisely why the manufacturer needs documentary visibility over both, and why an unverified distributor relationship is the most common point at which this visibility breaks down.

There is also a timing asymmetry worth building into the plan. The publication required by Article 18 is an act of the administration that the applicant cannot accelerate, so the gap between approval and a published entry must be treated as a scheduling item rather than as an administrative detail. If the commercial plan assumes that goods can move on the day the certificate is issued, that assumption is not supported by the text of the law.

4. Practical recommendations

1. When verifying a partner’s standing, require the certificate number and search the Official Gazette for the corresponding publication yourself. Where the two do not match, treat the product as unregistered until the discrepancy is explained in writing.
2. In import documentation, check three items side by side: the validity of the sanitary registration certificate, the import permit, and the authorization of the destination labeling. If any one is missing, stop the shipment.
3. For status changes such as a change of certificate holder or a renewal, require Gazette-level evidence of the update rather than only a new certificate, because the certificate alone does not establish when the change took effect.
4. Design import compliance controls around Article 67: complete a documented regulatory conformity self-check for every consignment before dispatch, and retain the record so that liability can be traced to a specific date.

5. Verification checklist

• □ Located the Gazette publication matching the certificate number of this project
• □ Confirmed that the product name and model recorded on the certificate match the goods to be imported exactly, including letters and suffixes
• □ Confirmed that the import permit is still valid on the date of shipment
• □ Confirmed that the destination labeling has been authorized
• □ Completed and filed the three pre-import checks required by Circular N° DGSACS-008/2026

Regulatory information verified as of October 29, 2026.

For a Venezuela market-entry feasibility assessment covering your specific product, contact the GRZAN regulatory team. GRZAN supports manufacturers, importers and authorized representatives with device registration in Venezuela: Gazette-level verification of certificates, Article 67 conformity reviews before dispatch, and documentation packages aligned with Circular N° DGSACS-008/2026. Reach us at info@grzanglobal.com.